Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-31

Clinical Trial Update: PTSD Prevention Using Escitalopram [NA]

View source ↗

Summary

A completed clinical trial from Sheba Medical Center evaluated escitalopram for the prevention of post-traumatic stress disorder. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: Sheba Medical Center | Conditions: Post-traumatic Stress Disorder | NA | Status: COMPLETED